ATE372128T1 - Angiogene proteine aus onchocerca volvulus sowie deren verwendung - Google Patents
Angiogene proteine aus onchocerca volvulus sowie deren verwendungInfo
- Publication number
- ATE372128T1 ATE372128T1 AT01920807T AT01920807T ATE372128T1 AT E372128 T1 ATE372128 T1 AT E372128T1 AT 01920807 T AT01920807 T AT 01920807T AT 01920807 T AT01920807 T AT 01920807T AT E372128 T1 ATE372128 T1 AT E372128T1
- Authority
- AT
- Austria
- Prior art keywords
- asp
- tissue
- factor
- present
- angiogenic proteins
- Prior art date
Links
- 102000008076 Angiogenic Proteins Human genes 0.000 title 1
- 108010074415 Angiogenic Proteins Proteins 0.000 title 1
- 241000243985 Onchocerca volvulus Species 0.000 title 1
- 230000033115 angiogenesis Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 230000002491 angiogenic effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/541,759 US6723322B1 (en) | 2000-04-03 | 2000-04-03 | Angiogenic Onchocerca volvulus proteins and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE372128T1 true ATE372128T1 (de) | 2007-09-15 |
Family
ID=24160920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01920807T ATE372128T1 (de) | 2000-04-03 | 2001-03-27 | Angiogene proteine aus onchocerca volvulus sowie deren verwendung |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6723322B1 (de) |
| EP (1) | EP1267917B1 (de) |
| AT (1) | ATE372128T1 (de) |
| AU (2) | AU2001247825B2 (de) |
| CA (1) | CA2403985C (de) |
| DE (1) | DE60130326T2 (de) |
| WO (1) | WO2001074385A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101151049A (zh) * | 2004-06-15 | 2008-03-26 | 纽约血液中心有限公司 | 旋盘尾丝虫的天然产物的佐剂和免疫加强性能 |
| WO2007111333A1 (ja) * | 2006-03-29 | 2007-10-04 | Toyo Boseki Kabushiki Kaisha | 核酸導入時の細胞障害を低減する方法 |
| WO2017165420A1 (en) * | 2016-03-21 | 2017-09-28 | Hawdon John M | Engineered human hookworms as a novel biodelivery system for vaccines and biologicals |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6177401B1 (en) | 1992-11-13 | 2001-01-23 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften | Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
-
2000
- 2000-04-03 US US09/541,759 patent/US6723322B1/en not_active Expired - Lifetime
-
2001
- 2001-03-27 EP EP01920807A patent/EP1267917B1/de not_active Expired - Lifetime
- 2001-03-27 AU AU2001247825A patent/AU2001247825B2/en not_active Ceased
- 2001-03-27 CA CA2403985A patent/CA2403985C/en not_active Expired - Fee Related
- 2001-03-27 AT AT01920807T patent/ATE372128T1/de not_active IP Right Cessation
- 2001-03-27 DE DE60130326T patent/DE60130326T2/de not_active Expired - Lifetime
- 2001-03-27 AU AU4782501A patent/AU4782501A/xx active Pending
- 2001-03-27 WO PCT/US2001/009798 patent/WO2001074385A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU4782501A (en) | 2001-10-15 |
| CA2403985A1 (en) | 2001-10-11 |
| DE60130326D1 (de) | 2007-10-18 |
| CA2403985C (en) | 2012-05-29 |
| WO2001074385A1 (en) | 2001-10-11 |
| EP1267917A4 (de) | 2004-06-09 |
| AU2001247825B2 (en) | 2005-01-06 |
| EP1267917B1 (de) | 2007-09-05 |
| US6723322B1 (en) | 2004-04-20 |
| DE60130326T2 (de) | 2008-05-29 |
| EP1267917A1 (de) | 2003-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE277034T1 (de) | Liponsaürederivate und deren verwendung bei der behandlung von krankheiten | |
| CY1107453T1 (el) | Baff, σχετικοι δεσμευτικοι παραγοντες και χρηση αυτων στη διεγερση και αναστολη β-κυτταρων και ανοσοσφαιρινων σε ανοσοαποκρισεις | |
| EP1411118A4 (de) | Zellproliferationsinhibitoren mit anti-glypican-3-antikörper | |
| DE60226499D1 (de) | Verwendung von antikörpern gegen das muc18-antigen | |
| ATE478670T1 (de) | Rezeptor-selektive cannabimimetische aminoalkylindole | |
| ATE358718T1 (de) | Integrin antagonisten | |
| ATE384732T1 (de) | Vegi, ein inhibitor der angiogenese und des tumorwachstums | |
| DE60123232D1 (de) | Tamandarin und didemnin analoga und methoden zu deren herstellung und verwendung | |
| DE59813690D1 (de) | Substituierte heterocyclen und deren verwendung in arzneimitteln | |
| ATE292801T1 (de) | Verfahren zum screening von inhibitoren von asp2 | |
| AR021946A1 (es) | Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas | |
| ATE413392T1 (de) | Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren | |
| ATE499098T1 (de) | Verwendung von parp-1-hemmern | |
| ATE395433T1 (de) | Screeningverfahren für geeignete wirkstoffe | |
| EP1742643A4 (de) | Modulation der glukose-6-phosphatase-translokase-expression | |
| DE60027905D1 (de) | Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung | |
| ATE372128T1 (de) | Angiogene proteine aus onchocerca volvulus sowie deren verwendung | |
| CY1119579T1 (el) | Μεθοδος για τη θεραπεια διαταραχων αναπτυξης της τριχας, οπως η γυναικειου τυπου αλωπεκια και συνεπως χρησιμα σκευασματα | |
| DE60328931D1 (de) | Wässrige Zubereitungen von Perfluoropolyetherphosphaten und ihre Verwendung für die ölabweisende Behandlung von Papier | |
| DE60113968D1 (de) | Diagnose von brustkrebs unter verwendung von bcmp-7 als marker | |
| DE60324387D1 (de) | Verwendung von amylin, amylinanaloga und amylin derivaten zur behandlung von dyslipidämie und hypertriglyceridämie | |
| BRPI0409475A (pt) | inibição de vav na rejeição de enxerto | |
| NO20060420L (no) | 2-aminobenzoylderivater | |
| DE59510674D1 (de) | Verwendung von selegilin zur behandlung von epileptischen erkrankungen | |
| DE60128084D1 (de) | Verwendung von inaktives cln2 proenzym zur behandlung von lincl |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |